Company Kuros Biosciences AG Swiss Exchange
Equities
CH0011025217
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- CHF | - |
04-24 | Kuros Biosciences Posts Higher Q1 Product Sales | MT |
04-17 | Kuros Biosciences AG Approves Board of Director and Committee Changes | CI |
Business Summary
Sales per Business
CHF in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Medical Devices
100.0
%
| 13 | 73.8 % | 34 | 100.0 % | +153.03% |
Sales per region
CHF in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
97.8
%
| 17 | 96.6 % | 33 | 97.8 % | +88.93% |
European Union
1.7
%
| 0 | 2.4 % | 1 | 1.7 % | +35.20% |
Other
0.4
%
| 0 | 1.0 % | 0 | 0.4 % | -17.82% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Joost de Bruijn
FOU | Founder | 58 | 03/12/17 |
Christopher Fair
CEO | Chief Executive Officer | 54 | 18/04/21 |
Daniel Geiger
DFI | Director of Finance/CFO | - | 16/02/23 |
Chief Tech/Sci/R&D Officer | - | 31/12/16 | |
Sjoerd Musters
COO | Chief Operating Officer | - | 30/09/22 |
Luuk van Dijk
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/14 |
Katherine Sage
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/20 |
John Griffin
PRN | Corporate Officer/Principal | - | 11/10/23 |
Marcel Borger
LAW | General Counsel | - | 31/12/19 |
Philippe Saudan
PRN | Corporate Officer/Principal | 57 | 09/08/16 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Scott P. Bruder
BRD | Director/Board Member | 62 | 13/06/18 |
Christopher Fair
CEO | Chief Executive Officer | 54 | 18/04/21 |
Joost de Bruijn
FOU | Founder | 58 | 03/12/17 |
Chairman | 67 | 22/05/17 | |
Oliver Walker
BRD | Director/Board Member | 55 | 13/06/18 |
Leanna Caron
BRD | Director/Board Member | 56 | 15/06/16 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 36,922,274 | 23,857,779 ( 64.62 %) | 17,244 ( 0.0467 %) | 64.62 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
KUROS BIOSCIENCES AG 3.15% | 1,160,106 | 3.15% | 7,805,309 $ |
Company contact information
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
+0.82% | 106B | |
+8.15% | 23.47B | |
-13.89% | 21.9B | |
-6.17% | 18.77B | |
-37.26% | 17.85B | |
-10.98% | 16.78B | |
+8.67% | 14.41B | |
+41.08% | 12.86B | |
+327.78% | 8.78B |
- Stock Market
- Equities
- KURN Stock
- Stock
- Company Kuros Biosciences AG